NCT04405167 2025-10-07
Tasquinimod for the Treatment of Relapsed or Refractory Myeloma
University of Pennsylvania
Phase 1 Terminated
Clinical Trials
9 trialsNCT02159950 2023-04-27
Sipuleucel-T With or Without Tasquinimod in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer
Roswell Park Cancer Institute
Phase 2 Completed
NCT02057666 2021-04-23
TasQ003
Ipsen
Phase 3 Terminated
NCT01732549 2019-11-22
A Proof of Concept Study of Maintenance Therapy With Tasquinimod in Patients With Metastatic Castrate-resistant Prostate Cancer Who Are Not Progressing After a First Line Docetaxel Based Chemotherapy
Ipsen
Phase 2 Terminated
NCT01743469 2019-01-08
A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers
Ipsen
Phase 2 Completed
NCT01513733 2018-09-04
CATCH
Duke University
Phase 1 Completed
NCT02396368 2015-11-20
Radium-223
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Withdrawn
NCT00560482 2015-10-26
Efficacy Study of ABR-215050 to Treat Prostate Cancer
Active Biotech AB
Phase 2 Completed
NCT01234311 2015-10-21
A Study of Tasquinimod in Men With Metastatic Castrate Resistant Prostate Cancer
Active Biotech AB
Phase 3 Completed